Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Broccoli, Alessandro"'
Autor:
Alessandro Pulsoni, Barbara Botto, Alessandro Re, Manuel Gotti, Michele Spina, Luigi Rigacci, Andrea Evangelista, Sofia Kovalchuk, Daniela Gioia, Lara Mannelli, Manjola Dona, Luca Nassi, Benedetta Puccini, Alessandro Broccoli, Caterina Stelitano, Flavia Salvi, Armando Santoro, Chiara Pagani, Pier Luigi Zinzani, Maurizio Bonfichi
FDG-positron emission tomography (PET) performed early during therapy in advanced Hodgkin lymphoma patients has been confirmed as being important for progression-free survival. A group of patients with a negative interim-PET (i-PET) showed a positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05cb996a2f3f72571286dbb535a49edb
http://hdl.handle.net/11573/1347613
http://hdl.handle.net/11573/1347613
Autor:
Maurizio Boaron, Luca Bertolaccini, Barbara Bonfanti, Sergio Nicola Forti Parri, Alessandro Broccoli, Claudio Agostinelli, Stefano Fanti, Lisa Argnani, Beatrice Casadei, Cinzia Pellegrini, Pier Luigi Zinzani, Cristina Nanni
Publikováno v:
Leukemialymphoma. 60(9)
Residual masses in patients with mediastinal lymphoma may be positron emission tomography (PET) positive during follow-up also in cases of complete response. The aim of this retrospective study is to verify the reliability of mediastinal PET-positive
Autor:
Caterina Stelitano, Alessandro Levis, Antonio Castagnoli, Gian Mauro Sacchetti, Daniela Gioia, Giovannino Ciccone, Vincenzo Pavone, Umberto Vitolo, Lisa Argnani, Ercole Brusamolino, Maurizio Bonfichi, Andrea Evangelista, Flavia Salvi, Roberto Freilone, Pier Luigi Zinzani, Gianluca Gaidano, Armando Santoro, Umberto Ricardi, Francesco Zaja, Giuseppe Rossi, Chiara Rusconi, Luigi Rigacci, Monica Tani, Eugenio Borsatti, Alessandro Pulsoni, Antonella Anastasia, Alessandro Broccoli, Patrizia Pregno
Publikováno v:
Journal of Clinical Oncology. 34:1376-1385
Purpose The clinical impact of positron emission tomography (PET) evaluation performed early during first-line therapy in patients with advanced-stage Hodgkin lymphoma, in terms of providing a rationale to shift patients who respond poorly onto a mor
Autor:
Caterina Stelitano, Waldemar Kulikowski, Alessandra Romano, Lisa Argnani, Luigi Rigacci, Alessandro Levis, Fabio Fuligni, Pier Paolo Piccaluga, Anna Borra, Randy D. Gascoyne, Francesco d'Amore, Bogdan Małkowski, Claudio Agostinelli, Edyta Subocz, Stefano Pileri, Pier Luigi Zinzani, Livio Trentin, Luisa Stracqualursi, Maria Teresa Sista, Stephen Hamilton-Dutoit, Caterina Patti, Claudio Tripodo, Andrea Gallamini, Jan Maciej Zaucha, Alessandro Broccoli, Stefano Fanti, Francesco Merli, Alberto Biggi, Christian Steidl, Justyna Rybka, Umberto Vitolo, Joanna Tajer, Patrizia Agati, Peter Kamper
Publikováno v:
Agostinelli, C, Gallamini, A, Stracqualursi, L, Agati, P, Tripodo, C, Fuligni, F, Sista, M T, Fanti, S, Biggi, A, Vitolo, U, Rigacci, L, Merli, F, Patti, C, Romano, A, Levis, A, Trentin, L, Stelitano, C, Borra, A, Piccaluga, P P, Hamilton-Dutoit, S, Kamper, P, Zaucha, J M, Małkowski, B, Kulikowski, W, Tajer, J, Subocz, E, Rybka, J, Steidl, C, Broccoli, A, Argnani, L, Gascoyne, R D, d'Amore, F, Zinzani, P L & Pileri, S A 2016, ' The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma : a retrospective, European, multicentre cohort study ', The Lancet. Haematology, vol. 3, no. 10, pp. e467-e479 . https://doi.org/10.1016/S2352-3026(16)30108-9
BACKGROUND: Early-interim fluorodeoxyglucose (FDG)-PET scan after two ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy courses (PET-2) represents the most effective predictor of treatment outcome in classical Hodgkin's lymphom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e938ba130f6b8eebdc3e9dca76c61cbe
https://hdl.handle.net/20.500.11769/542314
https://hdl.handle.net/20.500.11769/542314
Autor:
Pier Luigi Zinzani, Lisa Argnani, Melania Celli, Luigi Rigacci, Alessandro Pulsoni, Alessandro Broccoli, Cinzia Pellegrini, Maria Cantonetti, Antonello Pinto, Alessandro Re, Vincenzo Pavone
Hodgkin lymphoma (HL) is characterized by the presence of CD30-positive Hodgkin Reed-Sternberg cells. Approximately 30%-40% of patients with advanced disease are refractory to frontline therapy or will relapse after first-line treatment. The standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b876b57d6bd5796d6b60e9d4619414b
https://europepmc.org/articles/PMC4679088/
https://europepmc.org/articles/PMC4679088/
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma
Autor:
Lisa Argnani, Pier Luigi Zinzani, Letizia Gandolfi, Stefano Pileri, Cinzia Pellegrini, Beatrice Casadei, Enrico Derenzini, Vittorio Stefoni, Roberto Maglie, Alessandro Broccoli
The definition of the role of positron emission tomography (PET) in peripheral T-cell lymphomas (PTCLs) is still under investigation. The purpose of the present observational retrospective study was to assess the early prognostic value of PET after t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2c439bcadec523d991e9f65fac386f
https://europepmc.org/articles/PMC4077444/
https://europepmc.org/articles/PMC4077444/